Plasma Fractionation
A Global Strategic Business Report
MCP14015
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (1347)
54
CXO98
VICE PRESIDENT618
DIRECTOR454
MANAGER123
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Plasma Fractionation Market to Reach US$40.7 Billion by 2030
The global market for Plasma Fractionation estimated at US$30.2 Billion in the year 2024, is expected to reach US$40.7 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Albumin segment is estimated at 4.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$8.1 Billion While China is Forecast to Grow at 4.8% CAGR
The Plasma Fractionation market in the U.S. is estimated at US$8.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Global Plasma Fractionation Market - Key Trends and Drivers Summarized
Harnessing Vital Proteins: The Process of Plasma Fractionation
Plasma fractionation is a sophisticated biotechnological process used to separate and purify different components from blood plasma. Plasma, the liquid portion of blood, contains a variety of proteins and other substances essential for medical treatments. The fractionation process begins with the collection of plasma through donation. Once collected, the plasma undergoes a series of steps, including centrifugation, filtration, and chromatography, to isolate specific proteins. These proteins, such as albumin, immunoglobulins, and clotting factors, are then purified and concentrated for therapeutic use. Each step in the fractionation process is carefully controlled to ensure the purity, efficacy, and safety of the final products, which are used to treat a range of medical conditions, from immune deficiencies and bleeding disorders to shock and trauma.
How Are Plasma-Derived Products Utilized in Medicine?
Plasma-derived products play a critical role in modern medicine, offering life-saving treatments for various conditions. Albumin, one of the major proteins isolated through plasma fractionation, is used to treat patients with severe burns, liver diseases, and hypoalbuminemia by helping maintain blood volume and pressure. Immunoglobulins, or antibodies, are essential for treating immune deficiencies and autoimmune diseases. They provide passive immunity to patients, enhancing their ability to fight infections. Clotting factors, such as Factor VIII and Factor IX, are crucial for patients with hemophilia, a genetic disorder that impairs blood clotting. These products help prevent and control bleeding episodes, significantly improving the quality of life for hemophilia patients. The diverse applications of plasma-derived products underscore their importance in addressing a wide range of medical needs and enhancing patient care.
What Are the Current Trends in Plasma Fractionation Technology?
The plasma fractionation industry is continuously evolving, driven by advancements in technology and a growing understanding of plasma proteins. One significant trend is the improvement in purification techniques, such as advanced chromatography and filtration methods, which enhance the yield and purity of plasma-derived products. Another trend is the development of recombinant DNA technology, which allows for the production of certain plasma proteins in a laboratory setting, reducing dependence on plasma donations and increasing the availability of these critical therapies. The integration of automation and digital technologies is also transforming plasma fractionation, enabling more efficient and scalable production processes. Additionally, there is a growing focus on expanding the range of therapeutic applications for plasma-derived products, including the treatment of emerging diseases and conditions. These technological advancements and innovative approaches are shaping the future of plasma fractionation, making therapies more effective and accessible.
What Factors Are Driving the Growth in the Plasma Fractionation Market?
The growth in the plasma fractionation market is driven by several factors, each reflecting the increasing demand for plasma-derived therapies. The rising prevalence of chronic diseases and genetic disorders, such as hemophilia and primary immune deficiencies, is a significant driver, as these conditions require regular and long-term treatment with plasma-derived products. Technological advancements in fractionation processes and the development of recombinant therapies are enhancing the efficiency and scalability of production, meeting the growing demand. The expansion of healthcare infrastructure in developing regions is increasing access to plasma-derived therapies, contributing to market growth. Additionally, the aging global population is driving demand for treatments for age-related conditions, such as liver disease and immunodeficiencies. The emphasis on improving patient outcomes and the ongoing research into new therapeutic applications for plasma proteins further support market expansion. These factors collectively ensure robust growth in the plasma fractionation market, highlighting its critical role in modern healthcare and therapeutic development.
SCOPE OF STUDY
The report analyzes the Plasma Fractionation market by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors, Other Products); Application (Neurology, Immunology, Hematology, Oncology, Pulmonology, Other Applications); End-Use (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Bio Products Laboratory Ltd.; Biotest AG; China Biologic Products, Inc.; CSL Limited; Green Cross Corporation; Grifols SA; Japan Blood Products Organization; Kedrion SpA; LFB SA; Octapharma AG; Sanquin; Shanghai RAAS Blood Products Co., Ltd.; Shire PLC
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| Tariff Impact on Global Supply Chain Patterns |
| Global Economic Update |
| Plasma Fractionation: Overview & Outlook |
| Plasma Fractionation – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 47 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Intravenous Immunoglobulin Products Gain Traction |
| Rising Incidence of Respiratory Diseases: Major Driver |
| Growing Prevalence of Bleeding Disorders Bodes Well |
| Rise in AATD Cases Steers Demand |
| Advancements in Plasma Collection Technology Favor Growth |
| Recombinant Technology: Key Challenge |
| Rising Prevalence of Immunodeficiency Disorders Propels Market Growth |
| Advances in Fractionation Techniques and Technologies Drives Adoption |
| Increasing Use in Therapeutic Applications Expands Market Opportunities |
| Growth in Global Healthcare Expenditure Strengthens Business Case for Plasma Fractionation |
| Development of High-Purity and Potent Plasma-Derived Products Spurs Market Expansion |
| Increasing Focus on Rare Disease Treatments Accelerates Market Growth |
| Enhanced Safety and Efficacy of Fractionated Products Sustains Market Demand |
| Rising Investments in Plasma Fractionation Research Expands Addressable Market |
| Technological Innovations in Plasma Processing and Purification Strengthens Market Position |
| Development of Recombinant and Synthetic Plasma Products Generates Market Opportunities |
| Growth in Hemophilia and Coagulation Disorder Treatments Propels Market Growth |
| Increasing Demand for Immunoglobulins and Albumin Sustains Market Expansion |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Plasma Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Plasma Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Plasma Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Albumin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Protease Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Protease Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Protease Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Clinical Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Plasma Fractionation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Immunoglobulins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Immunoglobulins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Immunoglobulins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Pulmonology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| JAPAN |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| CHINA |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| EUROPE |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Plasma Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Plasma Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| FRANCE |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| GERMANY |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Plasma Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Plasma Fractionation by Product - Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Plasma Fractionation by Product - Percentage Breakdown of Value Sales for Immunoglobulins, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Products for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Plasma Fractionation by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Plasma Fractionation by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Plasma Fractionation by Application - Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Plasma Fractionation by Application - Percentage Breakdown of Value Sales for Neurology, Immunology, Hematology, Oncology, Pulmonology and Other Applications for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]